Recruiting
Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study
NCT07583511
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- SUN-YAT-SEN University Cancer Center Guangzhou, Guangdong, China